Citation Method of Allocation Blinding Loss to Use of Ceasing Reporting all Funding source randomisation concealment follow-up early outcome results for benefit where required McCarron Low risk Unclear risk Participants: 2% loss to Yes (low No (low Unclear risk Sandoz Research et al. (computer (method of low risk follow-up (low risk) risk) (Reported that Institute, National (1997) generated concealment of risk) creatinine, Institute of Diabetes Providers: low sequence) randomisation not albumin, haemocrit and Digestive and risk described) and haemoglobin Kidney Diseases, were unchanged National Institutes of Outcome but did not report Health (low risk) assessors: low specific results) risk Summary table Citation Study Population Intervention Outcomes Sample Compliance to Results & design level measured size duration sodium target location of relevant to (urinary data) research question
Citation Method of randomisation Allocation concealment Blinding Loss to follow-up Use of where required Ceasing early for benefit Reporting all outcome results Funding source McCarron et al. (1997) Low risk (computer generated sequence) Unclear risk (method of concealment of randomisation not described) Participants: low risk Providers: low risk Outcome assessors: low risk 2% loss to follow-up (low risk) Yes (low risk) No (low risk) Unclear risk (Reported that creatinine, albumin, haemocrit and haemoglobin were unchanged but did not report specific results) Sandoz Research Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (low risk) Summary table Citation & location Study design level of Population Intervention Outcomes measured relevant to research question Sample size duration Compliance to sodium target (urinary data) Results
Sodium%20Supporting%20Document%201%20%20Systematic%20Literature%20Review.docx